{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-25-029636","form_type":"8-K","ticker":"BFRG","cik":"0001829247","company_name":"BullFrog AI Holdings, Inc.","filed_at":"2025-12-30T23:59:59+00:00","discovered_at":"2026-05-14T18:02:40.662763+00:00","generated_at":"2026-05-16T12:01:06.130007+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.6,"confidence":"medium","headline":"BullFrog AI details 2025 progress, pharma partnerships, and 2026 catalysts","bullets":["Annual cash burn ~$6.2M; $10M equity line and ATM provide financing flexibility.","Multiple advanced pharma discussions for out-licensing or discovery collaborations with upfront/milestone payments.","Sygnature Discovery collaboration expected to generate revenue through 2028; sales kickoff in Sept 2025.","Eleison data from late-stage oncology collaboration accepted for ASCO GI Cancers Symposium Jan 9, 2026.","Launched bfPREP data prep tool; reduces data prep from months to days, enabling earlier engagement."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-25-029636","json":"https://secwatch.observer/filing/0001493152-25-029636.json","markdown":"https://secwatch.observer/filing/0001493152-25-029636.md","text":"https://secwatch.observer/filing/0001493152-25-029636.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1829247/000149315225029636/0001493152-25-029636-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1829247/000149315225029636/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T12:01:06.130007+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}